Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

The first study of people with diabetes and COVID-19 reveals troubling statistics and risk factors
Results from the VERTIS-CV trial show that SGLT-2 inhibitor Steglatro benefits heart and kidney health; hear expert opinions on SGLT-2 and GLP-1 medications
The RADIANT study aims to define unusual forms of diabetes, to help diagnose and treat these conditions. RADIANT is recruiting people who have been diagnosed with...
At the ADA Postgraduate 2021 virtual conference, Dr. Samuel Dagogo-Jack discussed how intensive lifestyle changes can lead to prediabetes remission and prevent...
Latest results presented at the European Society of Cardiology conference show that SGLT-2 inhibitor therapies Jardiance and Farxiga clearly lead to heart and kidney...
Experts discussed the greatest challenges in diabetes in 2020, including the COVID-19 pandemic, and the most critical changes we need to make to address them during...
Highlights from last week’s European Association for the Study of Diabetes’ (EASD) virtual 2020 conference included announcements on the Guardian Sensor 4 Continuous...
Recent results from Omada Health’s Digital Diabetes Prevention Program show reductions in A1C and body weight over a 12-month period. This digital tool may be especially...
Now that all adults in the US are eligible to receive a COVID-19 vaccine, we encourage everyone, especially people with diabetes or obesity, to get the vaccine as soon...
Two studies recently published on the Control-IQ and MiniMed 780G systems show that closed-loop automated insulin delivery significantly improves Time in Range.
To mark the hundredth anniversary of the discovery of insulin, the University of Toronto is hosting a series of presentations and seminars on the latest advances in...
Diabetes increases the risk of severe COVID-19 illness, but does the relationship between diabetes and the virus go in the other direction? Scientists are now studying...
Emerging evidence shows that variability in your A1C level may put you at a higher risk of stroke and heart disease.
How do our brains and bodies motivate us to eat? What makes us eat past the point of hunger? And how we can develop healthier eating habits?
New results on Eylea, a treatment for diabetes-related retinopathy, show that the therapy reduces the risk of more serious eye complications when used for prevention.
For decades, researchers have sought to develop a noninvasive method to measure blood glucose levels, which – if effective – could revolutionize diabetes care. One...
The American Diabetes Association's 81st Scientific Sessions brought together great minds in diabetes for exciting news and discussions. Check out highlights from the...
We’ve reviewed the latest research to weigh the benefits and drawbacks of intermittent fasting and time-restricted feeding for people with diabetes.
The discovery of insulin promised a new age for an ancient condition but introduced unexpected challenges. James S. Hirsch explores the riveting history of this miracle...
New results show that Vida Health’s digital diabetes coaching program led to meaningful reductions in A1C levels among people with type 2 diabetes, especially for those...

Pages